Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder.

Cohen BL, Caruso DJ, Kanagarajah P, Gousse AE.

Adv Urol. 2009:328364. doi: 10.1155/2009/328364. Epub 2009 Sep 8.

2.

Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.

Cohen BL, Barboglio P, Rodriguez D, Gousse AE.

Neurourol Urodyn. 2009;28(3):205-8. doi: 10.1002/nau.20611.

PMID:
19058190
3.

Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder.

Sahai A, Khan MS, Le Gall N, Dasgupta P; GKT Botulinum Study Group.

Urology. 2008 Mar;71(3):455-9. doi: 10.1016/j.urology.2007.11.039.

PMID:
18342186
4.

Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.

Sahai A, Dowson C, Khan MS, Dasgupta P.

BJU Int. 2009 Jun;103(11):1509-15. doi: 10.1111/j.1464-410X.2009.08402.x. Epub 2009 Apr 15.

5.

[Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].

Bentaleb Y, Castel-Lacanal E, Sallusto F, De Boissezon X, Malavaud B, Marque P, Rischmann P, Gamé X.

Prog Urol. 2008 Jul;18(7):449-55. doi: 10.1016/j.purol.2008.03.014. Epub 2008 May 27. French.

PMID:
18602606
6.

Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection.

Lucioni A, Rapp DE, Gong EM, Fedunok P, Bales GT.

Can J Urol. 2006 Oct;13(5):3291-5.

PMID:
17076955
7.

Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Gamé X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, Denys P, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Ruffion A, Soler JM, Saussine C.

J Pediatr Urol. 2009 Jun;5(3):156-64. doi: 10.1016/j.jpurol.2009.01.005. Epub 2009 Mar 4. Review.

PMID:
19264554
8.

Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability.

Makovey I, Davis T, Guralnick ML, O'Connor RC.

Neurourol Urodyn. 2011 Nov;30(8):1538-40. doi: 10.1002/nau.21150. Epub 2011 Aug 8.

PMID:
21826718
9.

Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.

Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ.

Eur Urol. 2008 Jul;54(1):181-7. doi: 10.1016/j.eururo.2007.12.029. Epub 2007 Dec 26.

PMID:
18191323
10.

Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?

Sahai A, Sangster P, Kalsi V, Khan MS, Fowler CJ, Dasgupta P.

BJU Int. 2009 Mar;103(5):630-4. doi: 10.1111/j.1464-410X.2008.08076.x. Epub 2008 Oct 16.

11.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E.

Eur Urol. 2008 Feb;53(2):275-87. Epub 2007 Oct 16. Review.

PMID:
17988791
13.

Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.

Hori S, Patki P, Attar KH, Ismail S, Vasconcelos JC, Shah PJ.

BJU Int. 2009 Jul;104(2):216-20. doi: 10.1111/j.1464-410X.2009.08368.x. Epub 2009 Feb 10.

14.

What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.

Khan S, Kessler TM, Apostolidis A, Kalsi V, Panicker J, Roosen A, Gonzales G, Haslam C, Elneil S, Fowler CJ, Dasgupta P.

J Urol. 2009 Apr;181(4):1773-8. doi: 10.1016/j.juro.2008.11.110. Epub 2009 Feb 23.

PMID:
19233414
15.

Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.

Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ.

Eur Urol. 2008 Jun;53(6):1245-53. doi: 10.1016/j.eururo.2008.02.037. Epub 2008 Mar 7.

PMID:
18343564
16.

Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women?

Zargham M, Abedi S, Alizadeh F, Khorami MH, Mohamadi M, Bahrami F, Sharifiaghdas F, Mazdak H.

Adv Biomed Res. 2017 Aug 31;6:113. doi: 10.4103/abr.abr_393_14. eCollection 2017.

17.

Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.

Kajbafzadeh A, Mahboubi AH, Payabvash S.

BJU Int. 2009 May;103(9):1248-54. doi: 10.1111/j.1464-410X.2008.08287.x. Epub 2008 Dec 22.

18.

Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.

Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A.

Eur Urol. 2009 Jun;55(6):1440-8. doi: 10.1016/j.eururo.2008.11.009. Epub 2008 Nov 18.

PMID:
19054608
19.

Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.

Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.

J Urol. 2009 Oct;182(4):1453-7. doi: 10.1016/j.juro.2009.06.023. Epub 2009 Aug 15.

PMID:
19683298
20.

Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.

Kim SH, Kim TB, Kim SW, Oh SJ.

J Urol. 2009 Jun;181(6):2550-4. doi: 10.1016/j.juro.2009.01.106. Epub 2009 Apr 16.

PMID:
19375103

Supplemental Content

Support Center